Old Second National Bank Of Aurora Raised Position in Ulta Salon Cosmetics & Fragrance (ULTA) by $1.02 Million; Lazard Asset Management Lifted Its Cvs Health (CVS) Position

February 19, 2018 - By Stephen Andrade

Lazard Asset Management Llc increased its stake in Cvs Health Corp (CVS) by 45.74% based on its latest 2017Q3 regulatory filing with the SEC. Lazard Asset Management Llc bought 105,581 shares as the company’s stock declined 4.23% while stock markets rallied. The institutional investor held 336,420 shares of the medical and nursing services company at the end of 2017Q3, valued at $27.36M, up from 230,839 at the end of the previous reported quarter. Lazard Asset Management Llc who had been investing in Cvs Health Corp for a number of months, seems to be bullish on the $72.84 billion market cap company. The stock increased 2.00% or $1.41 during the last trading session, reaching $71.9. About 6.47M shares traded. CVS Health Corporation (NYSE:CVS) has declined 24.40% since February 19, 2017 and is downtrending. It has underperformed by 41.10% the S&P500.

Old Second National Bank Of Aurora increased its stake in Ulta Salon Cosmetics & Fragrance Inc (ULTA) by 81.17% based on its latest 2017Q3 regulatory filing with the SEC. Old Second National Bank Of Aurora bought 4,518 shares as the company’s stock rose 6.88% with the market. The institutional investor held 10,084 shares of the 2007 company at the end of 2017Q3, valued at $2.28M, up from 5,566 at the end of the previous reported quarter. Old Second National Bank Of Aurora who had been investing in Ulta Salon Cosmetics & Fragrance Inc for a number of months, seems to be bullish on the $12.39 billion market cap company. The stock decreased 0.42% or $0.85 during the last trading session, reaching $203.15. About 1.06M shares traded. Ulta Beauty, Inc. (NASDAQ:ULTA) has risen 41.46% since February 19, 2017 and is uptrending. It has outperformed by 24.76% the S&P500.

Among 28 analysts covering Ulta Salon Cosmetics & Fragrance Inc (NASDAQ:ULTA), 16 have Buy rating, 0 Sell and 12 Hold. Therefore 57% are positive. Ulta Salon Cosmetics & Fragrance Inc had 110 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Ulta Beauty, Inc. (NASDAQ:ULTA) earned “Neutral” rating by PiperJaffray on Wednesday, October 18. RBC Capital Markets maintained it with “Sector Perform” rating and $270 target in Monday, August 29 report. The stock has “Outperform” rating by Robert W. Baird on Wednesday, August 24. The stock of Ulta Beauty, Inc. (NASDAQ:ULTA) earned “Market Perform” rating by Raymond James on Monday, May 9. Wells Fargo maintained Ulta Beauty, Inc. (NASDAQ:ULTA) rating on Thursday, January 11. Wells Fargo has “Buy” rating and $297.0 target. The firm has “Market Perform” rating by BMO Capital Markets given on Friday, August 25. The firm has “Hold” rating given on Thursday, November 30 by BMO Capital Markets. Deutsche Bank maintained the shares of ULTA in report on Friday, May 27 with “Hold” rating. The stock of Ulta Beauty, Inc. (NASDAQ:ULTA) earned “Hold” rating by Loop Capital on Thursday, February 9. The stock of Ulta Beauty, Inc. (NASDAQ:ULTA) has “Outperform” rating given on Friday, May 27 by Telsey Advisory Group.

Old Second National Bank Of Aurora, which manages about $240.35 million US Long portfolio, decreased its stake in Apple Computer Inc (NASDAQ:AAPL) by 3,114 shares to 38,594 shares, valued at $5.95M in 2017Q3, according to the filing. It also reduced its holding in Schlumberger Ltd (NYSE:SLB) by 12,294 shares in the quarter, leaving it with 3,190 shares, and cut its stake in J P Morgan Chase & Co (NYSE:JPM).

Since October 12, 2017, it had 1 insider purchase, and 0 selling transactions for $24.97 million activity.

Investors sentiment decreased to 0.85 in Q3 2017. Its down 0.20, from 1.05 in 2017Q2. It dived, as 102 investors sold ULTA shares while 170 reduced holdings. 68 funds opened positions while 163 raised stakes. 52.49 million shares or 1.02% less from 53.03 million shares in 2017Q2 were reported. Cornerstone Lc owns 10,001 shares. Wellington Gp Llp invested 0.11% of its portfolio in Ulta Beauty, Inc. (NASDAQ:ULTA). Oak Ridge Invs Limited Liability Co has invested 0.74% in Ulta Beauty, Inc. (NASDAQ:ULTA). Hartford Communication has invested 0.05% of its portfolio in Ulta Beauty, Inc. (NASDAQ:ULTA). Livforsakringsbolaget Skandia Omsesidigt holds 3,186 shares or 0.06% of its portfolio. Kepos Cap Limited Partnership accumulated 2,070 shares or 0.08% of the stock. Thompson Siegel Walmsley Ltd Liability holds 0% of its portfolio in Ulta Beauty, Inc. (NASDAQ:ULTA) for 104 shares. Moreover, Raymond James Na has 0.02% invested in Ulta Beauty, Inc. (NASDAQ:ULTA) for 1,098 shares. Axiom Investors Lc De accumulated 0.51% or 101,395 shares. Atlantic Trust Group Ltd Llc invested in 40,051 shares. California Pub Employees Retirement owns 136,743 shares. 189,765 are owned by Schwab Charles Invest Mngmt Inc. Missouri-based Scout has invested 0.2% in Ulta Beauty, Inc. (NASDAQ:ULTA). Pictet Asset Management, a United Kingdom-based fund reported 153,746 shares. Lombard Odier Asset Mngmt (Switzerland) Sa holds 20,000 shares.

Among 25 analysts covering CVS Health (NYSE:CVS), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. CVS Health had 72 analyst reports since July 22, 2015 according to SRatingsIntel. Needham maintained the shares of CVS in report on Tuesday, January 2 with “Buy” rating. Wolfe Research downgraded CVS Health Corporation (NYSE:CVS) on Monday, August 14 to “Peer Perform” rating. Loop Capital maintained CVS Health Corporation (NYSE:CVS) rating on Tuesday, November 7. Loop Capital has “Hold” rating and $73 target. Robert W. Baird maintained CVS Health Corporation (NYSE:CVS) on Thursday, January 4 with “Hold” rating. S&P Research maintained it with “Strong Buy” rating and $112 target in Monday, November 2 report. SunTrust maintained CVS Health Corporation (NYSE:CVS) on Friday, October 13 with “Buy” rating. As per Friday, January 22, the company rating was initiated by Robert W. Baird. The firm has “Outperform” rating given on Friday, February 9 by Leerink Swann. On Monday, November 2 the stock rating was maintained by Oppenheimer with “Outperform”. The firm earned “Buy” rating on Thursday, May 12 by Jefferies.

Investors sentiment decreased to 0.88 in 2017 Q3. Its down 0.04, from 0.92 in 2017Q2. It dived, as 60 investors sold CVS shares while 571 reduced holdings. 88 funds opened positions while 466 raised stakes. 801.45 million shares or 0.31% less from 803.96 million shares in 2017Q2 were reported. Wellington Shields Capital Mgmt reported 29,199 shares. Lathrop Invest invested in 3.31% or 143,955 shares. Moreover, Chevy Chase Trust Holdings has 0.55% invested in CVS Health Corporation (NYSE:CVS). Chase Invest Counsel owns 3,470 shares. Dnb Asset Management As holds 129,193 shares. Loomis Sayles & Lp has invested 0.05% in CVS Health Corporation (NYSE:CVS). Autus Asset Llc reported 5,431 shares stake. Aspiriant Ltd Liability Corporation reported 24,120 shares. Trustmark State Bank Department has invested 0.03% of its portfolio in CVS Health Corporation (NYSE:CVS). Welch Capital Prns Ltd Liability Ny accumulated 2% or 72,954 shares. Parsec Finance Management has invested 1.67% in CVS Health Corporation (NYSE:CVS). Green Square Cap Limited Liability Company reported 11,404 shares. Cornercap Inv Counsel Incorporated holds 0.66% or 58,120 shares. King Luther Cap reported 0.11% in CVS Health Corporation (NYSE:CVS). Tdam Usa reported 36,791 shares.

Lazard Asset Management Llc, which manages about $50.27B US Long portfolio, decreased its stake in Baidu Inc (NASDAQ:BIDU) by 121,248 shares to 5.76M shares, valued at $1.43 billion in 2017Q3, according to the filing. It also reduced its holding in Ati 4.75 7/1/22 (Prn) by 6.70M shares in the quarter, leaving it with 20.00M shares, and cut its stake in Ctxs 0.5 4/19 (Prn).

Since August 23, 2017, it had 0 insider buys, and 5 selling transactions for $38.09 million activity. Shares for $3.22 million were sold by Foulkes Helena on Friday, September 15. MERLO LARRY J had sold 241,150 shares worth $20.03 million. 237,078 CVS Health Corporation (NYSE:CVS) shares with value of $18.88M were sold by Denton David M. Roberts Jonathan C sold $7.13M worth of CVS Health Corporation (NYSE:CVS) on Monday, September 18.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: